These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 25984674)

  • 1. Amiodarone use is associated with increased risk of stroke in patients with nonvalvular atrial fibrillation: a nationwide population-based cohort study.
    Chen WC; Chen WC; Chen CY; Wu BR; Cheng WC; Lin KH; Hsia TC; Chen W; Chen CH; Muo CH; Liao WC; Li CH
    Medicine (Baltimore); 2015 May; 94(19):e849. PubMed ID: 25984674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Digoxin-amiodarone Combination is Associated With Excess All-cause Mortality in Patients With Atrial Fibrillation.
    Chiang JY; Chen PC; Yang YH; Chang CH; Chu FY; Chen JJ; Wu CK; Hwang JJ; Chiang FT; Lin LY; Lin JL
    Sci Rep; 2020 Mar; 10(1):4101. PubMed ID: 32139765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF).
    Washam JB; Stevens SR; Lokhnygina Y; Halperin JL; Breithardt G; Singer DE; Mahaffey KW; Hankey GJ; Berkowitz SD; Nessel CC; Fox KA; Califf RM; Piccini JP; Patel MR;
    Lancet; 2015 Jun; 385(9985):2363-70. PubMed ID: 25749644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
    DiMarco JP; Flaker G; Waldo AL; Corley SD; Greene HL; Safford RE; Rosenfeld LE; Mitrani G; Nemeth M;
    Am Heart J; 2005 Apr; 149(4):650-6. PubMed ID: 15990748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digoxin and Amiodarone on the Risk of Ischemic Stroke in Atrial Fibrillation: An Observational Study.
    Lai KC; Chen SJ; Lin CS; Yang FC; Lin CL; Hsu CW; Huang WC; Kao CH
    Front Pharmacol; 2018; 9():448. PubMed ID: 29867460
    [No Abstract]   [Full Text] [Related]  

  • 6. Increased mortality associated with digoxin in contemporary patients with atrial fibrillation: findings from the TREAT-AF study.
    Turakhia MP; Santangeli P; Winkelmayer WC; Xu X; Ullal AJ; Than CT; Schmitt S; Holmes TH; Frayne SM; Phibbs CS; Yang F; Hoang DD; Ho PM; Heidenreich PA
    J Am Coll Cardiol; 2014 Aug; 64(7):660-8. PubMed ID: 25125296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Ischemic Stroke, Major Bleeding, and Other Adverse Events With Warfarin Use vs Non-vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation With a History of Intracranial Hemorrhage.
    Tsai CT; Liao JN; Chiang CE; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chung FP; Chao TF; Lip GYH; Chen SA
    JAMA Netw Open; 2020 Jun; 3(6):e206424. PubMed ID: 32478848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes in patients with atrial fibrillation receiving amiodarone on NOACs vs. warfarin.
    Avendano R; Romero J; Lupercio F; Diaz JC; Quispe R; Golive A; Natale A; Garcia MJ; Krumerman AK; Di Biase L
    J Interv Card Electrophysiol; 2019 Jan; 54(1):73-80. PubMed ID: 30128801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preventing stroke by treating atrial fibrillation--new hope with dronedarone and dabigatran?].
    Röther J; Laufs U
    Dtsch Med Wochenschr; 2010 Mar; 135 Suppl 2():S55-8. PubMed ID: 20221980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amiodarone, anticoagulation, and clinical events in patients with atrial fibrillation: insights from the ARISTOTLE trial.
    Flaker G; Lopes RD; Hylek E; Wojdyla DM; Thomas L; Al-Khatib SM; Sullivan RM; Hohnloser SH; Garcia D; Hanna M; Amerena J; Harjola VP; Dorian P; Avezum A; Keltai M; Wallentin L; Granger CB;
    J Am Coll Cardiol; 2014 Oct; 64(15):1541-50. PubMed ID: 25301455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of suboptimal anticoagulation treatment with antiplatelet therapy and warfarin on clinical outcomes in patients with nonvalvular atrial fibrillation: A population-wide cohort study.
    Chan EW; Lau WC; Siu CW; Lip GY; Leung WK; Anand S; Man KK; Wong IC
    Heart Rhythm; 2016 Aug; 13(8):1581-8. PubMed ID: 27033342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does digoxin increase the risk of ischemic stroke and mortality in atrial fibrillation? A nationwide population-based cohort study.
    Chao TF; Liu CJ; Chen SJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chen TJ; Chiang CE; Chen SA
    Can J Cardiol; 2014 Oct; 30(10):1190-5. PubMed ID: 25262860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is either sotalol or amiodarone more effective than digoxin for converting patients with new-onset atrial fibrillation (AF) to sinus rhythm within 48 hours?
    Forney AJ; Schooff M
    J Fam Pract; 2000 Nov; 49(11):982. PubMed ID: 11093561
    [No Abstract]   [Full Text] [Related]  

  • 14. Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study.
    Bonde AN; Lip GY; Kamper AL; Hansen PR; Lamberts M; Hommel K; Hansen ML; Gislason GH; Torp-Pedersen C; Olesen JB
    J Am Coll Cardiol; 2014 Dec; 64(23):2471-82. PubMed ID: 25500231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Edoxaban vs. warfarin in patients with atrial fibrillation on amiodarone: a subgroup analysis of the ENGAGE AF-TIMI 48 trial.
    Steffel J; Giugliano RP; Braunwald E; Murphy SA; Atar D; Heidbuchel H; Camm AJ; Antman EM; Ruff CT
    Eur Heart J; 2015 Sep; 36(33):2239-45. PubMed ID: 25971288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective, randomized controlled trial comparing the efficacy and safety of sotalol, amiodarone, and digoxin for the reversion of new-onset atrial fibrillation.
    Joseph AP; Ward MR
    Ann Emerg Med; 2000 Jul; 36(1):1-9. PubMed ID: 10874228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of amiodarone use and outcomes in clinical practice for atrial fibrillation.
    Pokorney SD; Holmes DN; Shrader P; Thomas L; Fonarow GC; Mahaffey KW; Gersh BJ; Kowey PR; Naccarelli GV; Freeman JV; Singer DE; Washam JB; Peterson ED; Piccini JP; Reiffel JA
    Am Heart J; 2020 Feb; 220():145-154. PubMed ID: 31812756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticoagulation and amiodarone for new atrial fibrillation after coronary artery bypass grafting: Prescription patterns and 30-day outcomes in the United States and Canada.
    Matos JD; McIlvaine S; Grau-Sepulveda M; Jawitz OK; Brennan JM; Khabbaz KR; Sellke FW; Yeh R; Zimetbaum P
    J Thorac Cardiovasc Surg; 2021 Aug; 162(2):616-624.e3. PubMed ID: 32197901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amiodarone and risk of death in contemporary patients with atrial fibrillation: Findings from The Retrospective Evaluation and Assessment of Therapies in AF study.
    Ullal AJ; Than CT; Fan J; Schmitt S; Perino AC; Kaiser DW; Heidenreich PA; Frayne SM; Phibbs CS; Turakhia MP
    Am Heart J; 2015 Nov; 170(5):1033-1041.e1. PubMed ID: 26542514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hospitalized patients with atrial fibrillation compared to those included in recent trials on novel oral anticoagulants: a population-based study.
    Joppi R; Cinconze E; Mezzalira L; Pase D; Poggiani C; Rossi E; Pengo V;
    Eur J Intern Med; 2013 Jun; 24(4):318-23. PubMed ID: 23528931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.